RVVTF

Revive Therapeutics Ltd. RVVTF

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode RVVTF LOBEF TRUFF MYCOF CWBHF AQSZF RLFTF EHVVF CMPS
6M -26.06 % 12.22 % 2.43 % -25.93 % 89.60 % -30.00 % 25.85 % 30.00 % 126.49 %
YTD 134.62 % 51.50 % -16.91 % -66.94 % 73.27 % -46.15 % -18.50 % -13.33 % 64.82 %
1Y 87.69 % 124.44 % -11.23 % -67.74 % 39.66 % -77.17 % -42.64 % 225.00 % 15.15 %
3Y -93.74 % 88.20 % -63.86 % -99.62 % -78.21 % -94.81 % -64.42 % -52.73 % -29.41 %
5Y -93.41 % 88.20 % -89.46 % -99.42 % -93.97 % -97.63 % -98.38 % -88.39 % -81.98 %
10Y -97.68 % 88.20 % -89.46 % -99.42 % -98.65 % -99.49 % -76.64 % -99.74 % -76.41 %
From the beginning -97.68 % 88.20 % -89.46 % -99.42 % -98.65 % -99.49 % -76.64 % -99.74 % -76.41 %

Dividend